Senior Manager, Real World Evidence & Outcomes Research at Bristol-Myers Squibb

Madrid, Community of Madrid, Spain

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

University degree
Broad knowledge of all therapeutic areas and pharmaceutical marketplace, including industry, customers, competitors, and regulatory agencies
Expertise as a RWE&OR Specialist, including running sessions with internal and external experts to identify key outcomes research requirements
Strong critical thinking and problem-solving skills – identifying, investigating, and resolving issues
Executive communication skills – preparing and presenting deliverables
Ability to build and maintain strong relationships inside and outside the organization
Commitment to following and living company values and behaviors in search of patients’ benefit

Responsibilities

Lead the Real World Evidence (RWE) and Outcomes Research (OR) strategy for Spain and Portugal, securing the Localised-Integrated Evidence Generation Planning (L-IEGP) with collaboration from key departments (Medical, Access, HEOR…) and endorsement from the Leadership Team
Ensure BMS leads on innovative methods for RWE&OR providing value for healthcare and delivers sound strategies behind new products with value arguments tailored to stakeholders' needs
Lead the Governance process to secure the execution of the RWE&OR Strategy and Plan of Action
Lead the Publication plan with Medical and Access about RWE study results
Develop and drive RWE&OR strategies in collaboration with internal partners to ensure the value of medicines is fully supported by evidence both globally and locally
Increase internal awareness and understanding of RWE&OR and its relevance to driving the business; foster learning with internal and external partners to advance and evolve the RWE&OR Strategy
Apply rigor in study design and analytical methods; design fit-for-purpose analysis plans, assess effective ways of presenting results, implement/oversight studies including reporting, and ensure compliance with pharma industry regulations and standards
Secure alignment and collaboration with WW OR&RWE teams across areas of interest
Deliver Real World Evidence solutions according to affiliate priorities
Drive the interpretation, customization, and implementation of OR projects to support timely and effective access of innovative therapies in alignment with Medical/RCO, Commercial/Access, and Legal/Regulatory teams
Together with local Market Access and Medical teams, drive appropriate data generation to support future HTA submissions
Identify product ideas that contribute to real world evidence strategy and leverage OR argumentation through statistically validated publications
Prepare/adapt RWE presentations, submit communications to scientific meetings, and publish manuscripts in peer-reviewed journals
Promote the integration of RWE&OR into Market Access activities and develop effective communication tools and programs

Skills

Real World Evidence

Outcomes Research

HEOR

Evidence Generation Planning

RWE Strategy

Publication Planning

Stakeholder Collaboration

Governance

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free